BioMed Research International / 2020 / Article / Fig 3

Clinical Study

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Figure 3

The change trend of the absolute value of peripheral blood lymphocytes and T cells. (a) The change trend of the absolute value of peripheral blood lymphocytes in the glucocorticoid group and the nonglucocorticoid group. The change trend of the CD3+, CD4+, and CD8+ T cells in (b) the nonglucocorticoid group and (c) the glucocorticoid group. The change trend of (d) CD3+ T cells, (e) CD4+ T cells, and (f) CD8+ T cells in the glucocorticoid group (CS) and the nonglucocorticoid group (N-CS).
(a)
(b)
(c)
(d)
(e)
(f)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.